Kanyanatt Kanokwiroon

6PUBLICATIONS
14CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 25, 2023
Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of Thailand.

Panupong Sukpan, Surasak Sangkhathat, Hutcha Sriplung

|May 28, 2022
Interruptin C, a Radioprotective Agent, Derived from Cyclosorus terminans Protect Normal Breast MCF-10A and Human Keratinocyte HaCaT Cells against Radiation-Induced Damage.

Nipha Chumsuwan, Pasarat Khongkow, Sireewan Kaewsuwan

|Jan 21, 2022
Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells.

Siriphorn Chimplee, Sittiruk Roytrakul, Suchada Sukrong

|Sep 28, 2021
Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning.

Rassanee Bissanum, Sitthichok Chaichulee, Rawikant Kamolphiwong

|Jul 02, 2021
The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer.

Karan Ulhaka, Kanyanatt Kanokwiroon, Mattaka Khongkow

|May 24, 2019
Anticancer Potential of Fruit Extracts from Vatica diospyroides Symington Type SS and Their Effect on Program Cell Death of Cervical Cancer Cell Lines.

Atchara Chothiphirat, Kesara Nittayaboon, Kanyanatt Kanokwiroon

Pageof 1

Frequent Collaborators

2 joint publications

Raphatphorn Navakanitworakul

2 joint publications

Pasarat Khongkow

1 joint publications

Atchara Chothiphirat

1 joint publications

Theera Srisawat